AI assistant
Sending…
PAVmed Inc. — Director's Dealing 2018
Jan 3, 2018
35221_dirs_2018-01-03_3298df6d-0cec-4205-8e84-f0ec29655d7d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2017-12-21
Reporting Person: DeGuzman Brian J. (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-12-21 | Common Stock | J | 645346 | — | Acquired | 645346 | Indirect |
| 2017-12-21 | Common Stock | J | 645346 | — | Disposed | 0 | Indirect |
Footnotes
F1: Pro rata distribution from HCFP/Capital Partners III LLC, of which the trust is a non-managing member.
F2: Contribution to Pavilion Venture Partners LLC, of which the trust is a non-managing member.
More from PAVmed Inc.
Earnings Release
2026
May 15
Interim / Quarterly Report
2026
May 14
Proxy Solicitation & Information Statement
2026
May 1
Annual Report
2026
Apr 30
Earnings Release
2026
Mar 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Feb 24
Regulatory Filings
2026
Feb 17
Capital/Financing Update
2026
Feb 4
Regulatory Filings
2026
Jan 23